Novel pathway for sudden cardiac death prevention

Critical Pathways in Cardiology

Volumn 8, Issue 1, 2009, Pages 1-6

  Herzog, Eyal ^a   Aziz, Emad F ^a   Kukin, Marrick ^a   Steinberg, Jonathan S ^a   Mittal, Suneet ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Clinical pathway; Heart failure; ICD; Sudden cardiac death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALGORITHM; CAUSE OF DEATH; CLINICAL PATHWAY; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HEART CATHETERIZATION; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; NUCLEAR MAGNETIC RESONANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; REVIEW; SUDDEN DEATH; UNITED STATES; FEMALE; HEART INFARCTION; HEART STROKE VOLUME; MALE; METHODOLOGY; PHYSIOLOGY; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SURVIVAL; UTILIZATION REVIEW;

CORONARY ARTERY DISEASE; CRITICAL PATHWAYS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SURVIVAL ANALYSIS; UNITED STATES;

EID: 66949126573     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e318198c904     Document Type: Review

References (20)

1. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for practice guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol. 2006;48:e247-e346.
2. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337:1576-1583.
3. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
4. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
5. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
6. Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail. 2001;3:481-489.
7. O'Connor CM. The new heart failure guidelines: strategies for implementation. Am Heart J. 2007;153(suppl 4):2-5.
8. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-1465.
9. Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295:1901-1906.
10. Smy J. Improving patient care in cardiology. Nurs Times. 2004;100:24-25.
11. Cannon CP, Hand MH, Bahr R, et al. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. Am Heart J. 2002;143:777-789.
12. Herzog E, Saint-Jacques H, Rozanski A. The pain pathway as a tool to bridge the gap between evidence and management of acute coronary syndrome. Crit Pathw Cardiol. 2004;3:20-24.
13. Herzog E, Varley C, Kukin M. Pathway for the management of acute heart failure. Crit Pathw Cardiol. 2005;4:37-42.
14. Herzog E, Fischer A, Steinberg JS. The rate control, anticoagulation therapy, and electrophysiology/antiarrhythmic medication pathway for the management of atrial fibrillation and atrial flutter. Crit Pathw Cardiol. 2005;4:121-126.
15. Herzog E, Frankenberger O, Pierce W, et al. The SELF pathway for the management of syncope. Crit Pathw Cardiol. 2006;5:173-178.
16. Herzog E, Aziz E, Croitor S, et al. Pathway for the management of hyperglycemia in critical care units. Crit Pathw Cardiol. 2006;5:114-120.
17. Herzog E, Frankenberger O, Aziz E, et al. A novel pathway for the management of hypertension for hospitalized patients. Crit Pathw Cardiol. 2007;6: 150-160.
18. Hong MK, Herzog E, eds. Acute Coronary Syndrome: Multidisciplinary and Pathway Approach Book. (Translation of Critical Pathway for Acute Coronary Syndrome into Admission Note and Discharge Planning). London: Springer-Verlag; 2008:20-24. Chap. 3.
19. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American college of cardiology/American Heart Association Task Force on practice guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in Collaboration with the International Society for Heart and Lung Transplantation. Endorsed by the Heart Failure Society of America. Circulation. 2001;104:2996-3007.
20. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American college of cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to Revise the ACC/AHA/ NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1-e62.